The effect of achieving serological remission on subsequent risk of relapse, end-stage renal disease and mortality in ANCA-associated vasculitis: a target trial emulation study.
Journal Information
Full Title: Ann Rheum Dis
Abbreviation: Ann Rheum Dis
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Competing interests: ZSW has performed consultancy for Viela Bio/Horizon, MedPace, Zenas Biopharma, and Sanofi/Principia. ZSW has received grant support from BMS and Sanofi/Principia for unrelated work."
"Funding: GCM is supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32AR055855). ZSW is supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (K23AR073334 and R03AR078938), the Rheumatology Research Foundation (K Supplement), and a COVID-19 Junior Investigator Award from the Massachusetts General Hospital Department of Medicine. Competing interests:ZSW has performed consultancy for Viela Bio/Horizon, MedPace, Zenas Biopharma, and Sanofi/Principia. ZSW has received grant support from BMS and Sanofi/Principia for unrelated work."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025